Content by U.S. Food and Drug Administration

|2 min read

FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection

The FDA has approved Hepcludex, the first treatment for chronic hepatitis D virus infection, offering a new option for patients at risk of severe liver complications
|2 min read

FDA Launches Initiative to Advance Drug Repurposing for Unmet Medical Needs

The agency is particularly focused on new uses to treat chronic or rare diseases, substance use disorders
|2 min read

FDA Announces Major Steps to Implement Real-Time Clinical Trials

Agency unveils real-time trial proofs-of-concept and upcoming pilot program
|3 min read

FDA Fast-Tracks Ultra-Rare Therapies with Plausible Mechanism Guidance

Framework enables approval of individualized genome editing and RNA-based treatments when traditional trials aren’t feasible
|3 min read

FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease

New test provides less invasive option, reduces reliance on PET scans, and increases diagnosis accessibility
|3 min read

FDA Marketing Authorization Enables Increased Access to First Step of Syphilis Diagnosis

First home antibody test can inform patients of current or past infection and lead to confirmatory testing with healthcare provider
|3 min read

Disruptions in Availability of BD BACTEC Blood Culture Media Bottles—Letter to Healthcare Providers

The US is experiencing interruptions in the supply of BD BACTEC blood culture media bottles because of recent supplier issues
|3 min read

First Point-of-Care Hepatitis C Test Authorized by FDA

The RNA-based test enables single-visit testing for HCV in about an hour, streamlining access to treatment
|3 min read

FDA Releases New Principles for Machine Learning-Enabled Medical Devices

The new guiding principles promote transparency to build trust and improve the user experience of machine learning-enabled medical devices
|5 min read

FDA Takes Aim at Ensuring the Safety and Effectiveness of Laboratory Developed Tests

The FDA announced a final rule amending the FDA’s regulations to make explicit that IVDs are devices under the Federal Food, Drug, and Cosmetic Act
Updated |3 min read

FDA Approves New Antibiotic for Multiple Bacterial Infections

The FDA granted the approval of Zevtera® to Basilea Pharmaceutica International Ltd.
|2 min read

FDA Approves First Nonsteroidal Drug for DMD

The FDA granted the approval of Duvyzat™ to Italfarmaco S.p.A
Page 1 of 8